The VICC.ORG Directory of Doctors, Healthcare Providers & Researchers
Liana DesHarnais Castel, Ph.D.
See also:
Assistant Professor of Medicine
VICC Member
Researcher
Contact Information:
Vanderbilt Medical Center, General Internal Medicine and Public Health
2525 West End Avenue, 6th Floor
Nashville, TN 37203-1738
615-343-9798
Fax: 615-936-8545
Profile
Dr. Castel is an Assistant Professor in the Department of General Internal Medicine, and is a member of the Vanderbilt Ingram Cancer Center, Vanderbilt Institute for Medicine and Public Health, and the Division of Epidemiology/Vanderbilt Epidemiology Center. She teaches epidemiologic methods in the Vanderbilt Doctoral Program in Epidemiology.
Read more ....
Dr. Castel is an Assistant Professor in the Department of General Internal Medicine, and is a member of the Vanderbilt Ingram Cancer Center, Vanderbilt Institute for Medicine and Public Health, and the Division of Epidemiology/Vanderbilt Epidemiology Center. She teaches epidemiologic methods in the Vanderbilt Doctoral Program in Epidemiology. In 2010 Castel was awarded a five-year Mentored Research Scholar Grant in Applied and Clinical Research career development award from the American Cancer Society.
Dr. Castel received her PhD from the University of North Carolina at Chapel Hill in Epidemiology, her MSPH in Health Policy and Administration, and her BA in Psychology and French (also from UNC-CH). She has studied predictors of longitudinal pain outcomes in patients with metastatic breast cancer and also worked on the PROMIS (Patient-Reported Outcomes Measurement Information System) study, conducting a qualitative analysis within the Social Well-Being domain. Castel is the founder and Principal Investigator of BRE0939 at VICC (the Breast Cancer Adjuvant Therapy [BCAT] longitudinal cohort study). Research interests include cancer survivorship and health outcomes issues including secondary effects of and adherence to adjuvant endocrine therapy/aromatase inhibitors, clinical effectiveness of therapies, personalized medicine, patient preferences, racial disparities, and other PROs in cancer and chronic disease. She is married to a French citizen and holds certification from the U.S. Department of Defense in French written and spoken communication.
Publications
- Hahn, EA, Devellis, RF, Bode, RK, Garcia, SF, Castel, LD, Eisen, SV, Bosworth, HB, Heinemann, AW, Rothrock, N, Cella, D, , Measuring social health in the patient-reported outcomes measurement information system (PROMIS): item bank development and testing. Qual Life Res, 19(7), 1035-44, 2010.
- Freburger, JK, Carey, TS, Holmes, GM, Wallace, AS, Castel, LD, Darter, JD, Jackman, AM Exercise prescription for chronic back or neck pain: who prescribes it? who gets it? What is prescribed. Arthritis Rheum, 61(2), 192-200, 2009.
- Castel, LD, Freburger, JK, Holmes, GM, Scheinman, RP, Jackman, AM, Carey, TS Spine and pain clinics serving North Carolina patients with back and neck pain: what do they do, and are they multidisciplinary. Spine (Phila Pa 1976), 34(6), 615-22, 2009.
- Freburger, JK, Holmes, GM, Agans, RP, Jackman, AM, Darter, JD, Wallace, AS, Castel, LD, Kalsbeek, WD, Carey, TS The rising prevalence of chronic low back pain. Arch Intern Med, 169(3), 251-8, 2009.
- Castel, LD, Freburger, JK, Scheinman, RP, Jackman, AM, Carey, TS "A survey of pain clinics that treat back and neck pain in North Carolina: what do they do, and are they multidisciplinary?." Spine, 34(6), 615-622, 2008.
- Castel, LD, Williams, KA, Bosworth, HB, Eisen, SV, Hahn, EA, Irwin, DE, Kelly, MA, Morse, J, Stover, A, DeWalt, DA, DeVellis, RF Content validity in the PROMIS social-health domain: a qualitative analysis of focus-group data. Qual Life Res, 17(5), 737-49, 2008.
- Freburger, J, Carey, T, Holmes, G, Wallace, A, Castel, L, Darter, J, & Jackman, A "Exercise prescription for chronic back or neck pain: Who prescribes it? Who gets it? What is prescribed?." In press, Arthritis Care & Research, 61(2), 192-200, 2008.
- Castel, LD, Saville, BR, Depuy, V, Godley, PA, Hartmann, KE, Abernethy, AP Racial differences in pain during 1 year among women with metastatic breast cancer: a hazards analysis of interval-censored data. Cancer, 112(1), 162-70, 2008.
- Freburger, JK, Holmes, GM, Agans, RP, Jackman, AM, Darter, JD, Wallace, AS, Castel, LD, Kalsbeek, WD, Carey, TS "The rising prevalence of chronic low back pain." Archives of Internal Medicine, 169(3), 251-258, 2008.
- DePuy, V, Anstrom, KJ, Castel, LD, Schulman, KA, Weinfurt, KP, Saad, F Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer. Support Care Cancer, 15(7), 869-76, 2007.
- Castel, LD, Abernethy, AP, Li, Y, Depuy, V, Saville, BR, Hartmann, KE Hazards for pain severity and pain interference with daily living, with exploration of brief pain inventory cutpoints, among women with metastatic breast cancer. J Pain Symptom Manage, 34(4), 380-92, 2007.
- Weinfurt, KP, Anstrom, KJ, Castel, LD, Schulman, KA, Saad, F Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer. Ann Oncol, 17(6), 986-9, 2006.
- Weinfurt, KP, Anstrom, KJ, Castel, LD, Schulman, KA, Saad, F "Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer." Annals of Oncology, 17(6), 986-989, 2006.
- Weinfurt, KP, Li, Y, Castel, LD, Saad, F, Timbie, JW, Glendenning, GA, Schulman, KA The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer. Ann Oncol, 16(4), 579-84, 2005.
- Weinfurt, KP, Li, Y, Castel, LD, Saad, F, Timbie, JW, Glendenning, GA, Schulman, KA "The significance of skeletal-related events for the health-related quality of life of patients with metastic prostate cancer." Annals of Oncology, 16(4), 579-584, 2005.
- Weinfurt, KP, Depuy, V, Castel, LD, Sulmasy, DP, Schulman, KA, Meropol, NJ Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trials. Cancer, 103(1), 140-7, 2005.
- Gaskin, DJ, Weinfurt, KP, Castel, LD, DePuy, V, Li, Y, Balshem, A, Benson, A, Burnett, CB, Corbett, S, Marshall, J, Slater, E, Sulmasy, DP, Van Echo, D, Meropol, NJ, Schulman, KA An exploration of relative health stock in advanced cancer patients. Med Decis Making, 24(6), 614-24, 2004.
- Weinfurt, KP, Castel, LD, Li, Y, Timbie, JW, Glendenning, GA, Schulman, KA Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions. Med Care, 42(2), 164-75, 2004.
- Meropol, NJ, Castel, LD, Schulman, KA, Weinfurt, KP "Physician-patient communication in phase I cancer trials." Journal of Clinical Oncology, 22(3), 572-573, 2004.
- Fedida, D, Eldstrom, J, Hesketh, JC, Lamorgese, M, Castel, L, Steele, DF, Van Wagoner, DR Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes. Circ Res, 93(8), 744-51, 2003.
- Meropol, NJ, Weinfurt, KP, Burnett, CB, Balshem, A, Benson, AB, Castel, L, Corbett, S, Diefenbach, M, Gaskin, D, Li, Y, Manne, S, Marshall, J, Rowland, JH, Slater, E, Sulmasy, DP, Van Echo, D, Washington, S, Schulman, KA Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol, 21(13), 2589-96, 2003.
- Weinfurt, KP, Castel, LD, Li, Y, Sulmasy, DP, Balshem, AM, Benson, AB, Burnett, CB, Gaskin, DJ, Marshall, JL, Slater, EF, Schulman, KA, Meropol, NJ The correlation between patient characteristics and expectations of benefit from Phase I clinical trials. Cancer, 98(1), 166-75, 2003.
- Castel, LD, Timbie, JW, Sendersky, V, Curtis, LH, Feather, KA, Schulman, KA Toward estimating the impact of changes in immigrants'' insurance eligibility on hospital expenditures for uncompensated care. BMC Health Serv Res, 3(1), 1, 2003.
- Seils, DM, Castel, LD, Curtis, LH, Weinfurt, KP Welfare reform and Latinas'' use of perinatal health care. Am J Public Health, 92(5), 699-700; author reply 700, 2002.
- DesHarnais Castel, L, Bajwa, K, Markle, JP, Timbie, JW, Zacker, C, Schulman, KA A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone disease. Support Care Cancer, 9(7), 545-51, 2001.
- DesHarnais Castel, L, Bajwa, K, Markle, JP, Timbie, JW, Zacker, C, Schulman, KA "A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastic bone disease." Supportive Care in Cancer, 9(7), 545-551, 2001.
- Dranitsaris, G, Castel, LD, Baladi, JF, Schulman, K "Zoledronic acid versus pamidronate as palliative therapy in cancer patients: A Canadian time and motion analysis." Journal of Oncology Pharmacy Practice, 7(1), 27-33, 2001.
You do not have JavaScript enabled. This site works better with JavaScript turned on.
